J. W. Coons Advisors, LLC Gilead Sciences, Inc. Transaction History
J. W. Coons Advisors, LLC
- $527 Million
- Q2 2024
A detailed history of J. W. Coons Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J. W. Coons Advisors, LLC holds 10,335 shares of GILD stock, worth $910,306. This represents 0.13% of its overall portfolio holdings.
Number of Shares
10,335
Previous 10,659
3.04%
Holding current value
$910,306
Previous $780,000
9.1%
% of portfolio
0.13%
Previous 0.14%
Shares
17 transactions
Others Institutions Holding GILD
# of Institutions
1,893Shares Held
1.02BCall Options Held
12MPut Options Held
9.04M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.72 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.32 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.23 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...